BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 3157787)

  • 1. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
    Najafi A; Hutchison N
    J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental crossover study between hydroxymethylene diphosphonate kit and methylene diphosphonate (author's transl)].
    Nagai K; Muranaka A; Otsuka N; Terashima H; Yanagimoto S; Nagase N; Ito Y
    Radioisotopes; 1982 Jan; 31(1):32-4. PubMed ID: 6461888
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid and precise micro-methods for quantitating active components in commercial bone scintigraphy kits--II. Diphosphonates.
    Gallez B; Osinski P; Adline J; Dumont P
    Int J Rad Appl Instrum A; 1988; 39(9):1011-4. PubMed ID: 2848784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
    Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
    Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro stability of 99Tcm bone scan preparations from different manufacturers measured by various radiopharmaceutical parameters.
    Pauwels EK; Feitsma RI
    Nucl Med Commun; 1984 Jul; 5(7):467-72. PubMed ID: 6099535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magistral preparation of methylene diphosphonate and its clinical evaluation in radionuclide diagnosis of the skeleton].
    Lepej J; Marosová A; Altmann P; Reznák I; Podmajerský M
    Cesk Farm; 1989 Jul; 38(5):204-9. PubMed ID: 2790989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pH on the formation of Tc(NaBH4)-MDP radiopharmaceutical analogues.
    Tanabe S; Zodda JP; Deutsch E; Heineman WR
    Int J Appl Radiat Isot; 1983 Dec; 34(12):1577-84. PubMed ID: 6230322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversed-phase HPLC of 99mTc methylene diphosphonate bone imaging kits with quantification of pertechnetate.
    Hoch DJ; Pinkerton TC
    Int J Rad Appl Instrum A; 1986; 37(7):593-8. PubMed ID: 3021661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dissolved oxygen on Tc-99m methylene diphosphonate: concise communication.
    Coupal JJ; Kim EE; DeLand FH
    J Nucl Med; 1981 Feb; 22(2):153-6. PubMed ID: 6450824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m-alendronate: a new radiopharmaceutical for bone scanning.
    Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina C; Sepúlveda-Méndez J
    Arch Med Res; 1996; 27(4):481-3. PubMed ID: 8987181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-MDP extraction in relation to 81mKr perfusion following a partial osteotomy in the dog tibia.
    Khan RA
    Experientia; 1980 Oct; 36(10):1193-4. PubMed ID: 6448160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An evaluation of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) as a new bone scanning agent (author's transl)].
    Hayashi M; Takahashi K; Furukawa K; Hazue M; Shibatsuji H; Yasuda N; Tanaka K; Yoshikawa I; Maeda K; Hamada S
    Radioisotopes; 1981 Jan; 30(1):38-9. PubMed ID: 7268059
    [No Abstract]   [Full Text] [Related]  

  • 15. 99mTc bone scanning agents--III. Preparation and gel chromatography of 99mTc(Sn)MDP complexes.
    Kroesbergen J; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):419-24. PubMed ID: 3710704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
    Rudd TG; Allen DR; Hartnett DE
    J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
    Littlefield JL; Rudd TG
    J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
    Rudd TG; Allen DR; Smith FD
    J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labeling efficiency and stomach concentration in methylene diphosphonate bone imaging.
    Dhawan V; Yeh SD
    J Nucl Med; 1979 Jul; 20(7):791-3. PubMed ID: 541718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.